News
NOTV
4.270
-1.16%
-0.050
Weekly Report: what happened at NOTV last week (0113-0117)?
Weekly Report · 16h ago
Inotiv (NOTV) Gets a Buy from Lake Street
TipRanks · 3d ago
Cambodian NHP suspension neutral to positive for Inotiv, says Lake Street
TipRanks · 3d ago
Weekly Report: what happened at NOTV last week (0106-0110)?
Weekly Report · 01/13 10:49
Weekly Report: what happened at NOTV last week (1230-0103)?
Weekly Report · 01/06 10:56
INOTIV, INC. COMPLETES EQUITY OFFERING FOR NET PROCEEDS OF APPROXIMATELY $3.6 MILLION
Reuters · 12/30/2024 21:05
Monday Sector Laggards: Biotechnology, Computer Peripherals
NASDAQ · 12/30/2024 17:58
Weekly Report: what happened at NOTV last week (1223-1227)?
Weekly Report · 12/30/2024 10:51
Insider Purchase: Director at $NOTV (NOTV) Buys 23,529 Shares
NASDAQ · 12/24/2024 03:00
INOTIV, INC. COMPLETES EQUITY OFFERING FOR NET PROCEEDS OF APPROXIMATELY $24.0 MILLION
Reuters · 12/23/2024 21:05
Inotiv’s Strategic Moves and Financial Outlook Support Buy Rating
TipRanks · 12/23/2024 13:45
Lazard Enhanced Opportunities Portfolio Q3 2024 Commentary
Seeking Alpha · 12/23/2024 12:45
Weekly Report: what happened at NOTV last week (1216-1220)?
Weekly Report · 12/23/2024 10:57
BUZZ-U.S. STOCKS ON THE MOVE-BioAge Labs, Expedia, Citizens Financial Group
Reuters · 12/18/2024 18:47
Inotiv Shares Drop on $25.5 Mln Public Offering
Dow Jones · 12/18/2024 14:24
Inotiv Announces Pricing Of Underwritten Public Offering - Quick Facts
NASDAQ · 12/18/2024 13:23
BUZZ-Inotiv tumbles on pricing stock offering
Reuters · 12/18/2024 13:22
Inotiv Announces Pricing Of Public Offering Of 6M Common Shares Of Common Stock At A Price Of $4.25/Share
Benzinga · 12/18/2024 13:21
Inotiv prices 6M shares at $4.25 in underwritten public offering
TipRanks · 12/18/2024 13:11
Inotiv stock plummets on pricing of public offering of 6M common shares
Seeking Alpha · 12/18/2024 13:09
More
Webull provides a variety of real-time NOTV stock news. You can receive the latest news about Inotiv Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOTV
More
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.